Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post GOP senators express ‘concerns,’ ‘skepticism’ over Trump’s spending bill after Musk rant June 4, 2025 Next Post S&P 500 Bullish Patterns: Are Higher Highs Ahead? June 4, 2025 Related Posts Juggernaut Closes $1,100,000 from Institutions and Accredited Investors July 9, 2025 Quimbaya Gold July 9, 2025 Share Purchase Plan Offer Booklet July 9, 2025